The largest international cancer survival study to date, it found the chances of surviving for at least five years after being diagnosed with cancer ranged from a low of 25.2 percent for men in Poland to 57.9 percent for women in France. Regionally, Scandinavia came out best and Eastern Europe worst.
That compares with a survival rate of 62 percent for men and 63.5 percent for women in the United States. Comparable statistics for other areas of the world were not immediately available.
For a more detailed breakdown of the European results see this chart. Unfortunately, that chart does not include the United States. For data on how far ahead the US is of Canada for cancer survival rates (hint: half the US states are ahead of Canada's best province BC) see here for a comparison of American states and Canadian provinces.
The sheer amount of money spent makes a difference.
Germany spent 10.6 per cent of gross domestic product on healthcare, France spends 9.5 per cent. Britain, by contrast, spends 7.6 per cent.
The United States, by contrast, spends substantially more (about 14% and rising in 2002) as a percentage of GDP on health care than any European country.
A more rapid adoption of new approaches seems to characterize the American system. (my bold emphasis added)
Between 1990 and 2000, US prostate cancer mortality fell by one third at ages 50-74, and it fell by one quarter at ages 75-84. Definite decreases are also beginning to be seen in the UK, France and some other European countries.
Early detection, prompt surgery and hormonal treatments are all contributing, according to Professor Sir Richard Peto, from the University of Oxford, UK
|Share |||By Randall Parker at 2003 September 26 05:07 PM Socialism, Capitalism|